Search

everythinglearnresearchcommunity

for

Search:↓

Up to 10% of hair loss patients might have early signs of a condition called Lichen Planopilaris.

Androgenetic alopecia in Nepalese men often starts around age 29, with a possible link to COVID-19 worsening the condition.

Trichoscopic measurements help determine the severity of female pattern hair loss.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

High AMH levels are linked to PCOS in women and may have a male equivalent with similar traits.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Androgenetic alopecia is significantly linked to metabolic syndrome.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

25% of women in North Sudan have traction alopecia, linked to family history and hair treatments, highlighting the need for better hair care awareness.

Certain metabolites can either protect against or increase the risk of hair loss.

Finasteride may lower cholesterol and slow heart disease progression.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Men with baldness, ear creases, and hairy ears have a higher risk of heart disease.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Minoxidil shortens baldness from chemotherapy by 50.2 days without significant side effects.

The formulation with oleic acid may be better for treating male pattern baldness.

IMA may indicate oxidative stress in skin and hair disorders, but more research is needed.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

Hormonal imbalances can cause hair loss, and understanding them can help develop better treatments.

PCOS is a common hormonal disorder in women that causes various symptoms and health risks, requiring personalized treatment.

Hair growth serums A and C can affect hair growth genes and pathways, suggesting potential for personalized hair loss treatments.